E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Standard · 3 min
The Diagnostic Journey of Dysautonomia Patients: Insights from a Patient-Reported Outcome Study.
O'Dell, John A, Walker, Ash, Latham, Andrew J et al. · Journal of patient experience · 2025 · DOI
Quick Summary
This study followed 672 adults with dysautonomia (a condition where the nervous system that controls automatic body functions doesn't work properly) to understand how long it takes to get diagnosed and which doctors help with diagnosis. On average, it took 7.7 years for people to receive a diagnosis, and they often saw multiple types of doctors before getting answers. The study found that dysautonomia commonly occurs alongside other conditions like Ehlers-Danlos syndrome, mast cell disorders, and ME/CFS, which can make diagnosis even more confusing.
Why It Matters
For ME/CFS patients, this study is relevant because dysautonomia frequently co-occurs with ME/CFS and the two conditions often create diagnostic confusion that delays treatment. Understanding the common obstacles in diagnosing dysautonomia—including symptom overlap with ME/CFS and other conditions—can help both patients and clinicians recognize the need for interdisciplinary evaluation and reduce the years of suffering before accurate diagnosis.
Observed Findings
Average time to diagnosis was 7.7 years (SD 10 years) among 672 dysautonomia patients.
Cardiologists were the most common specialists to make the initial diagnosis, followed by neurologists and primary care physicians.
Common comorbidities included Ehlers-Danlos syndrome, mast cell disorders, vitamin deficiency, fibromyalgia, and myalgic encephalomyelitis (ME/CFS).
Symptom overlap with other conditions was identified as a major barrier to timely diagnosis.
Limited access to autonomic specialists was noted as a hindering factor in the diagnostic process.
Inferred Conclusions
Prolonged diagnostic delays in dysautonomia contribute to increased morbidity and compound psychological and economic burden for patients.
The symptom overlap between dysautonomia and comorbid conditions (including ME/CFS) confounds the diagnostic process and extends time-to-diagnosis.
Increased clinical awareness among both healthcare providers and patients about dysautonomia and its diagnostic barriers is needed to reduce morbidity and improve outcomes.
Multidisciplinary care involving cardiology, neurology, and primary care may be necessary for accurate diagnosis given the multi-system nature of dysautonomia.
Remaining Questions
What This Study Does Not Prove
This study does not establish what causes the diagnostic delay or prove that delayed diagnosis directly worsens outcomes—only that they are associated. The cross-sectional design and reliance on patient recall cannot determine the causal mechanisms behind the 7.7-year average delay or whether earlier diagnosis would have definitively improved health outcomes. The study does not establish prevalence rates or compare diagnostic journeys across different healthcare systems.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →